The invention relates to an ex vivo generated population of tissue-specific anti-inflammatory macrophages and methods of making and using such macrophages
Hematti, Peiman, Eric G. Schmuck, John A. Kink, and Amish N. Raval. "Generation of therapeutic cells using extracellular components of target organs." U.S. Patent Application 15/941,409, filed October 4, 2018.
View full article